Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution

US9089533B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9089533-B2
Application numberUS-201013321499-A
CountryUS
Kind codeB2
Filing dateMay 19, 2010
Priority dateMay 19, 2009
Publication dateJul 28, 2015
Grant dateJul 28, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of decreasing the ratio visceral adipose tissue to subcutaneous adipose tissue in preterm infants and infants small for gestational age, the method comprising: (a) mixing human milk with a human milk fortifier, comprising: (i) at least 20% protein based on total calories, (ii) at least 5% fat based on total calories, wherein the fat comprises from 0.15 wt. % to 4 wt. % docosahexaenoic acid based on total fatty acids, to produce a fortified human milk, and (b) administering the fortified human milk to a preterm infant or infant small for gestational age in need thereof, wherein administration of the fortified human milk results in growth without development of excess visceral adipose tissue. 2. The method according to claim 1 , comprising administering 0.1 -20 g dry weight of the human milk fortifier per day. 3. The method according to claim 1 , wherein the infant is small for gestational age. 4. A method of promoting catch up growth in infants small for gestational age, the method comprising: (a) mixing human milk with a human milk fortifier, comprising: (i) at least 20% protein based on total calories, (ii) at least 5% fat based on total calories, wherein the fat comprises from 0.15 wt. % to 4 wt. % docosahexaenoic acid based on total fatty acids, to produce a fortified human milk, and (b) administering the fortified human milk to an infant small for gestational age in need thereof, wherein administration of the fortified human milk results in growth without development of excess visceral adipose tissue. 5. The method according to claim 4 , comprising administering 0.1 -20 g dry weight of the human milk fortifier per day.

Assignees

Inventors

Classifications

  • Cyclic peptides {, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C (A61K38/043 - A61K38/046 take precedence)} · CPC title

  • Polyunsaturated fatty acids · CPC title

  • Docosahexaenoic acid · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Fatty acids or derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9089533B2 cover?
The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.
Who is the assignee on this patent?
Van Der Beek Eline Marleen, Boehm Günther, Beermann Christopher, and 3 more
What technology area does this patent fall under?
Primary CPC classification A61K35/20. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).